Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) Completed Phase 4 Trials for Poliomyelitis / Diphtheria / Tetanus / Pertussis / Haemophilus Infections Prevention

Indications	Status	Purpose	Phase
DBCOND0013769 (Poliomyelitis) DBCOND0000394 (Diphtheria) DBCOND0000386 (Tetanus) DBCOND0014696 (Pertussis) DBCOND0033285 (Haemophilus Infections)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00802867	Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis fimbriae 2/3 antigen (DB10790) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (DB10787) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)